Xiaohui Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Xiaohui Jiang has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Ying Shen
Department of Obstetrics/Gynecology Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE West China Second University Hospital Sichuan University Chengdu China
4 shared publications Chuan Jiang
Department of Obstetrics/Gynecology, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University , Chengdu, Sichuan
3 shared publications- Ding-Ming Li
Human Sperm Bank, West China Second University Hospital of Sichuan University, Chengdu, China
3 shared publications - Hengzhou Bai
Andrology Department, West China Second University Hospital, Sichuan University
3 shared publications Kun Tian
Department of Andrology and Human Sperm Bank, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
3 shared publications- Yi Zheng
Andrology Department, West China Second University Hospital, Sichuan University
3 shared publications
Latest Publications
- 11 April 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (2)
Investigating the role of a testis-expressed gene Tex2 in spermatogenesis in mice
The testis-expressed (TEX/Tex) genes are highly expressed in the testes of various species. Several members of the TEX catalog have been suggested to play a role in spermatogenesis, but the functions of most members remain unknown. Here, we initially confirmed that TEX2 is significantly upregulated in spermatids and further successfully generated a Tex2 knockout (KO) mouse model using CRISPR/Cas9 technology. However, we found that the Tex2 KO male mice were fertile. Interestingly, Papanicolaou staining and scanning electron microscopy showed slight abnormalities in sperm morphology and reduced sperm motility as assessed by computer-assisted sperm analysis in Tex2 KO mice. Collectively, despite Tex2 having enriched expression in mouse testis, our genetic KO studies revealed that Tex2 is not essential for spermatogenesis or fertility in male mice, although its absence in sperm causes subtle abnormalities in morphology and motility.
- 11 April 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (2)
Investigating the role of a testis-expressed gene Tex2 in spermatogenesis in mice
The testis-expressed (TEX/Tex) genes are highly expressed in the testes of various species. Several members of the TEX catalog have been suggested to play a role in spermatogenesis, but the functions of most members remain unknown. Here, we initially confirmed that TEX2 is significantly upregulated in spermatids and further successfully generated a Tex2 knockout (KO) mouse model using CRISPR/Cas9 technology. However, we found that the Tex2 KO male mice were fertile. Interestingly, Papanicolaou staining and scanning electron microscopy showed slight abnormalities in sperm morphology and reduced sperm motility as assessed by computer-assisted sperm analysis in Tex2 KO mice. Collectively, despite Tex2 having enriched expression in mouse testis, our genetic KO studies revealed that Tex2 is not essential for spermatogenesis or fertility in male mice, although its absence in sperm causes subtle abnormalities in morphology and motility.
- Open Access
- 1 January 2026
- Published by Wiley in Andrologia
- Vol. 2026 (1)
Exploratory Multiomics Profiling Reveals ACTN4‐Centric Cytoskeletal Failure and Environmental Arsenic Association in Morphologically Defined Oligoasthenoteratospermia Subtypes
Background: Oligoasthenoteratospermia (OAT) represents a major cause of male infertility. The molecular mechanisms underlying sperm morphological defects, particularly their potential interplay with environmental exposure‐associated molecular alterations, remain poorly understood and warrant exploratory investigation. Methods: Semen and plasma samples were collected from normal controls (NC, n = 6), mild morphological defect (MMD, n = 6), and severe morphological defect (SMD, n = 6) subjects in this exploratory pilot study designed to detect large‐effect signals. Integrated proteometabolomic profiling was performed using 4D proteomics and LC–MS. Bioinformatic analysis focused on screening differential expression, functional enrichment, exploring potential interactions between exposure‐associated metabolites and proteins, and identifying coherent patterns to potentially differentiate groups. Results: Comparative analysis identified biphasic dysregulation patterns in key cytoskeletal proteins. The prominent hub ACTN4 exhibited depletion in MMD sperm while displaying pathological spatial dislocation with 83% showing midpiece signal loss and fragmented tail fluorescence, accompanied by extracellular vesicle release in SMD sperm. Quantitative immunofluorescence validation confirmed these divergent phenotypes, that is a 56% systemic reduction in MMD compared to controls ( p < 0.0001), with SMD sperm also showing 41% absolute depletion versus NC ( p < 0.0001) despite proteomic upregulation, which indicates functional loss through vesicular shedding. Plasma metabolomics revealed distinct profiles between severity groups, quantifying 357 differentially abundant metabolites (including prioritized selenometabolite‐bile acid interactions) between SMD and MMD. Exploratory correlation analysis prioritized inverse associations including arsenocholine (an established environmental arsenic exposure biomarker) and ACTN4 ( ρ = −0.867, p = 0.0025), glycodeoxycholic acid versus PPP1CC ( ρ = −0.917, p < 0.001), and Se‐adenosylselenomethionine‐PGK1 ( ρ = −0.867, p = 0.0025), reflecting ultrastructural damage patterns. Conclusion: This severity‐stratified analysis demonstrates that sperm morphological defects in OAT associate with compartment‐specific ACTN4 depletion patterns, that is quantitative loss systemically impairing head‐tail coupling in MMD versus spatial dislocation with pathological vesiculation causing functional nullification in SMD. The exploratory findings suggest potential associations with multisystem exposure effects, particularly indicated by the arsenocholine‐ACTN4 correlation, though causal relationships cannot be established from this observational study. In addition, exposure‐protein associations involving PPP1CC and PGK1 also support the hypothesis of environmental perturbation affecting sperm integrity, though these observations require validation in independent cohorts.
- 1 January 2026
- Published by Wiley in Andrologia
- Vol. 2026 (1)
Open AccessExploratory Multiomics Profiling Reveals ACTN4‐Centric Cytoskeletal Failure and Environmental Arsenic Association in Morphologically Defined Oligoasthenoteratospermia Subtypes
Background: Oligoasthenoteratospermia (OAT) represents a major cause of male infertility. The molecular mechanisms underlying sperm morphological defects, particularly their potential interplay with environmental exposure‐associated molecular alterations, remain poorly understood and warrant exploratory investigation. Methods: Semen and plasma samples were collected from normal controls (NC, n = 6), mild morphological defect (MMD, n = 6), and severe morphological defect (SMD, n = 6) subjects in this exploratory pilot study designed to detect large‐effect signals. Integrated proteometabolomic profiling was performed using 4D proteomics and LC–MS. Bioinformatic analysis focused on screening differential expression, functional enrichment, exploring potential interactions between exposure‐associated metabolites and proteins, and identifying coherent patterns to potentially differentiate groups. Results: Comparative analysis identified biphasic dysregulation patterns in key cytoskeletal proteins. The prominent hub ACTN4 exhibited depletion in MMD sperm while displaying pathological spatial dislocation with 83% showing midpiece signal loss and fragmented tail fluorescence, accompanied by extracellular vesicle release in SMD sperm. Quantitative immunofluorescence validation confirmed these divergent phenotypes, that is a 56% systemic reduction in MMD compared to controls ( p < 0.0001), with SMD sperm also showing 41% absolute depletion versus NC ( p < 0.0001) despite proteomic upregulation, which indicates functional loss through vesicular shedding. Plasma metabolomics revealed distinct profiles between severity groups, quantifying 357 differentially abundant metabolites (including prioritized selenometabolite‐bile acid interactions) between SMD and MMD. Exploratory correlation analysis prioritized inverse associations including arsenocholine (an established environmental arsenic exposure biomarker) and ACTN4 ( ρ = −0.867, p = 0.0025), glycodeoxycholic acid versus PPP1CC ( ρ = −0.917, p < 0.001), and Se‐adenosylselenomethionine‐PGK1 ( ρ = −0.867, p = 0.0025), reflecting ultrastructural damage patterns. Conclusion: This severity‐stratified analysis demonstrates that sperm morphological defects in OAT associate with compartment‐specific ACTN4 depletion patterns, that is quantitative loss systemically impairing head‐tail coupling in MMD versus spatial dislocation with pathological vesiculation causing functional nullification in SMD. The exploratory findings suggest potential associations with multisystem exposure effects, particularly indicated by the arsenocholine‐ACTN4 correlation, though causal relationships cannot be established from this observational study. In addition, exposure‐protein associations involving PPP1CC and PGK1 also support the hypothesis of environmental perturbation affecting sperm integrity, though these observations require validation in independent cohorts.
- 14 August 2025
- Published by Springer Nature in Human Genetics
- Vol. 144 (9-10) , 971-982
Biallelic loss-of-function variants of DNAH7 cause male infertility associated with asthenozoospermia in humans
Although variants in DNAH family genes have been suggested as a main contributor to asthenozoospermia in humans, the role of DNAH7 on male fertility remains largely unexplored. In this study, loss-of-function variants in DNAH7 were identified in two unrelated infertile men with asthenozoospermia through whole exome sequencing, including compound heterozygous variants c.9702_9705del (p.Phe3234Leufs*52) and c.768G > A (p.Trp256*) in Patient 1, and compound heterozygous variants c.5650 C > T (p.Arg1884*) and c.768G > A (p. Trp 256*) in Patient 2. Interestingly, transmission electron microscopy results indicated a severe loss of inner dynein arms (IDAs) in the sperm flagella of both patients. Furthermore, immunofluorescent staining revealed a marked reduction of DNAH7 and other IDA-associated proteins, such as DNAH3 and DNAH6, in the patients' spermatozoa. In contrast, the expression of the outer dynein arms (ODA)-associated proteins, including DNAH8, DNAH11, DNAH17 and DNAI1, was comparable to that in normal controls. Moreover, the infertility of the patients harboring DNAH7 mutations could be successfully overcome by intracytoplasmic sperm injection treatment. Taken together, our findings confirmed that DNAH7 variants may contribute to asthenozoospermia by affecting flagellar IDA assembly, thereby enhancing our understanding of phenotype-genotype correlations in male infertility.
- 14 August 2025
- Published by Springer Nature in Human Genetics
- Vol. 144 (9-10) , 971-982
Biallelic loss-of-function variants of DNAH7 cause male infertility associated with asthenozoospermia in humans
Although variants in DNAH family genes have been suggested as a main contributor to asthenozoospermia in humans, the role of DNAH7 on male fertility remains largely unexplored. In this study, loss-of-function variants in DNAH7 were identified in two unrelated infertile men with asthenozoospermia through whole exome sequencing, including compound heterozygous variants c.9702_9705del (p.Phe3234Leufs*52) and c.768G > A (p.Trp256*) in Patient 1, and compound heterozygous variants c.5650 C > T (p.Arg1884*) and c.768G > A (p. Trp 256*) in Patient 2. Interestingly, transmission electron microscopy results indicated a severe loss of inner dynein arms (IDAs) in the sperm flagella of both patients. Furthermore, immunofluorescent staining revealed a marked reduction of DNAH7 and other IDA-associated proteins, such as DNAH3 and DNAH6, in the patients' spermatozoa. In contrast, the expression of the outer dynein arms (ODA)-associated proteins, including DNAH8, DNAH11, DNAH17 and DNAI1, was comparable to that in normal controls. Moreover, the infertility of the patients harboring DNAH7 mutations could be successfully overcome by intracytoplasmic sperm injection treatment. Taken together, our findings confirmed that DNAH7 variants may contribute to asthenozoospermia by affecting flagellar IDA assembly, thereby enhancing our understanding of phenotype-genotype correlations in male infertility.
- Open Access
- 21 March 2025
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 23 (1) , 1-8
Comparison of outcomes between pulsatile gonadotropin releasing hormone and combined gonadotropin therapy of spermatogenesis in patients with congenital hypogonadotropic hypogonadism
To evaluate whether there was a difference in outcome between pulsatile gonadotropin releasing hormone (GnRH) therapy and human chorionic gonadotropin/human menopausal gonadotropin (hCG/HMG) therapy for induction of spermatogenesis in post-pubertal male patients with congenital hypogonadotropic hypogonadism (CHH). This was a single-center retrospective cohort study conducted at the Andrology Center of a university hospital. A total of 155 postpubertal CHH patients who met the inclusion criteria underwent spermatogenic induction at the same andrology center. All patients used pulsatile GnRH therapy or hCG/HMG therapy for at least 6 months. The effects of spermatogenic induction therapy and testicular growth were evaluated. Logistic regression analysis was used to identify statistically significant factors which could predict the outcome of treatment. There was no difference in the efficiency of successfully inducing spermatogenesis between pulsatile GnRH therapy and hCG/HMG therapy (82.1% vs. 75.8%, P: 0.356), nor was there a difference in sperm concentration category (SCC) (P: 0.284). However, the mean time required for pulsatile GnRH therapy was shorter (12.34 vs. 14.74 months, P: 0.038). At the treatment endpoint, total testicular volume (TTV) was greater with pulsatile GnRH therapy compared with hCG/HMG therapy (15 vs. 12 ml, P: 0.010), and there was still no difference in SCC (P: 0.310). Multivariate logistic regression analysis showed that only baseline TTV was statistically significant predictor of induced spermatogenic success (odds ratio, OR: 1.156, 95% confidence interval, CI: 1.013, 1.319). The area under receiver operating characteristic curve was 0.635, a sensitivity of 0.661, and a specificity of 0.588. In addition, multiple linear regression analysis demonstrated that younger age at treatment initiation and higher baseline TTV were significantly associated with increased sperm concentration at the end of treatment. Pulsatile GnRH therapy was similar to hCG/HMG therapy in inducing spermatogenesis in post-pubertal CHH patients, but it took less time and was more beneficial to testicular development. Larger baseline TTV may mean a better spermatogenic outcome. It was necessary for patients to have more information about spermatogenesis therapy in order to make reasonable medical decisions. Chinese Clinical Trial Registry. ChiCTR2400086876. Retrospectively registered on July 5, 2024.
- 21 March 2025
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 23 (1) , 1-8
Open AccessComparison of outcomes between pulsatile gonadotropin releasing hormone and combined gonadotropin therapy of spermatogenesis in patients with congenital hypogonadotropic hypogonadism
To evaluate whether there was a difference in outcome between pulsatile gonadotropin releasing hormone (GnRH) therapy and human chorionic gonadotropin/human menopausal gonadotropin (hCG/HMG) therapy for induction of spermatogenesis in post-pubertal male patients with congenital hypogonadotropic hypogonadism (CHH). This was a single-center retrospective cohort study conducted at the Andrology Center of a university hospital. A total of 155 postpubertal CHH patients who met the inclusion criteria underwent spermatogenic induction at the same andrology center. All patients used pulsatile GnRH therapy or hCG/HMG therapy for at least 6 months. The effects of spermatogenic induction therapy and testicular growth were evaluated. Logistic regression analysis was used to identify statistically significant factors which could predict the outcome of treatment. There was no difference in the efficiency of successfully inducing spermatogenesis between pulsatile GnRH therapy and hCG/HMG therapy (82.1% vs. 75.8%, P: 0.356), nor was there a difference in sperm concentration category (SCC) (P: 0.284). However, the mean time required for pulsatile GnRH therapy was shorter (12.34 vs. 14.74 months, P: 0.038). At the treatment endpoint, total testicular volume (TTV) was greater with pulsatile GnRH therapy compared with hCG/HMG therapy (15 vs. 12 ml, P: 0.010), and there was still no difference in SCC (P: 0.310). Multivariate logistic regression analysis showed that only baseline TTV was statistically significant predictor of induced spermatogenic success (odds ratio, OR: 1.156, 95% confidence interval, CI: 1.013, 1.319). The area under receiver operating characteristic curve was 0.635, a sensitivity of 0.661, and a specificity of 0.588. In addition, multiple linear regression analysis demonstrated that younger age at treatment initiation and higher baseline TTV were significantly associated with increased sperm concentration at the end of treatment. Pulsatile GnRH therapy was similar to hCG/HMG therapy in inducing spermatogenesis in post-pubertal CHH patients, but it took less time and was more beneficial to testicular development. Larger baseline TTV may mean a better spermatogenic outcome. It was necessary for patients to have more information about spermatogenesis therapy in order to make reasonable medical decisions. Chinese Clinical Trial Registry. ChiCTR2400086876. Retrospectively registered on July 5, 2024.
- 18 October 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 212,p. e67148
Optimizing the Modified No-Scalpel Vasectomy Technique
No-scalpel vasectomy (NSV) is a commonly used contraceptive method for males. In previous applications of this surgical method, issues such as knot detachment and postoperative recanalization resulted in a reduced contraceptive success rate after vasectomy. This new technique innovatively modifies the ligation procedure during NSV to address knot detachment and postoperative recanalization. Two ligations of the testicular end of the vas deferens and one ligation of the abdominal end are completed before transection of the vas deferens. A fourth ligation of the abdominal end is performed using the suture tails of the third ligature of the testicular end after transection of the vas deferens. The fifth ligation of the abdominal end is performed using the suture tails of the first ligature of the testicular end. These modifications strengthen the ligations and reduce the postoperative recanalization rate. Additionally, the two stumps are gathered together, creating better conditions for a possible vasovasostomy in the future, thereby achieving overall better outcomes with vasectomy.
- 18 October 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 212,p. e67148
Optimizing the Modified No-Scalpel Vasectomy Technique
No-scalpel vasectomy (NSV) is a commonly used contraceptive method for males. In previous applications of this surgical method, issues such as knot detachment and postoperative recanalization resulted in a reduced contraceptive success rate after vasectomy. This new technique innovatively modifies the ligation procedure during NSV to address knot detachment and postoperative recanalization. Two ligations of the testicular end of the vas deferens and one ligation of the abdominal end are completed before transection of the vas deferens. A fourth ligation of the abdominal end is performed using the suture tails of the third ligature of the testicular end after transection of the vas deferens. The fifth ligation of the abdominal end is performed using the suture tails of the first ligature of the testicular end. These modifications strengthen the ligations and reduce the postoperative recanalization rate. Additionally, the two stumps are gathered together, creating better conditions for a possible vasovasostomy in the future, thereby achieving overall better outcomes with vasectomy.
- Open Access
- 23 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (8) , e37201
Case report: remedial microdissection testicular sperm extraction after onco-microdissection testicular sperm extraction failure
Background: Testicular cancer (TC) mostly occurs in men aged 14 to 44. Studies have shown that TC seriously damages male fertility, and 6% to 24% of patients with TC were even found to suffer from azoospermia when they are diagnosed. At present, some studies have pointed out that onco-microdissection testicular sperm extraction (mTESE) can extract sperm from tumor testicles. However, there are almost no reports on remedial measures after onco-mTESE failure. Given the valuable opportunity for fertility preservation in patients with TC and azoospermia, it is necessary to provide effective remedial methods for patients with failed onco-mTESE. Methods: Two young men, who were diagnosed with TC and also found to have azoospermia, tried onco-mTESE while undergoing radical orchiectomy for fertility preservation. However, sperm extraction failed in both patients. Subsequently, the isolated testicular tissue of the patient in case 1 suffered from TC again, and the patient in case 2 was scheduled to receive multiple cycles of gonadotoxic chemotherapy. Because both had a plan to have a birth in the future, we performed remedial mTESE. Results: Sperm was successfully extracted from both patients. The patient recovered well, without complications. The patient couple in case 1 underwent 1 intracytoplasmic sperm injection (ICSI) cycle but did not achieve clinical pregnancy. Conclusions: There is still an opportunity to extract sperm successfully using onco-mTESE, despite the difficulty of fertility preservation in TC patients with azoospermia. If sperm extraction from the tumor testis fails, implementing remedial mTESE as early as possible would likely preserve the last chance of fertility for these patients.
- 23 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (8) , e37201
Open AccessCase report: remedial microdissection testicular sperm extraction after onco-microdissection testicular sperm extraction failure
Background: Testicular cancer (TC) mostly occurs in men aged 14 to 44. Studies have shown that TC seriously damages male fertility, and 6% to 24% of patients with TC were even found to suffer from azoospermia when they are diagnosed. At present, some studies have pointed out that onco-microdissection testicular sperm extraction (mTESE) can extract sperm from tumor testicles. However, there are almost no reports on remedial measures after onco-mTESE failure. Given the valuable opportunity for fertility preservation in patients with TC and azoospermia, it is necessary to provide effective remedial methods for patients with failed onco-mTESE. Methods: Two young men, who were diagnosed with TC and also found to have azoospermia, tried onco-mTESE while undergoing radical orchiectomy for fertility preservation. However, sperm extraction failed in both patients. Subsequently, the isolated testicular tissue of the patient in case 1 suffered from TC again, and the patient in case 2 was scheduled to receive multiple cycles of gonadotoxic chemotherapy. Because both had a plan to have a birth in the future, we performed remedial mTESE. Results: Sperm was successfully extracted from both patients. The patient recovered well, without complications. The patient couple in case 1 underwent 1 intracytoplasmic sperm injection (ICSI) cycle but did not achieve clinical pregnancy. Conclusions: There is still an opportunity to extract sperm successfully using onco-mTESE, despite the difficulty of fertility preservation in TC patients with azoospermia. If sperm extraction from the tumor testis fails, implementing remedial mTESE as early as possible would likely preserve the last chance of fertility for these patients.
- Open Access
- 26 August 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (34) , e30350
Case report: Biallelic variants in POLR3B gene lead to 4H leukodystrophy from the study of brother and sister
Introduction: 4H leukodystrophy, one of POLR3-related leukodystrophy, is a rare hereditary brain white matter disease caused by the pathogenic biallelic variations in POLR3A, POLR3B, or POLR1C. Hypomyelination, hypodontia, and hypogonadotropic hypogonadism is mainly presented in patients with 4H leukodystrophy. Patient concerns: Here, we reported the brother and the sister with new compound heterozygous (c.1615G>T and c.165-167del) with various degrees of phenotypes including dysbasia, myopia, dental abnormal, and hypogonadotropic hypogonadism. Diagnosis: The brother and sister were diagnosed with 4H leukodystrophy. Interventions: Gonadotrophins treatment of the brother could significantly improve the development of secondary sexual characteristics and genitalia. Outcomes: This study showed that the same genotype of POLR3B may have variable clinical phenotypes in the brother and sister. Conclusion: The exploration of molecular functions and genetic counseling are crucial for further diagnosis and treatment of POLR3-related leukodystrophy.
- 26 August 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (34) , e30350
Open AccessCase report: Biallelic variants in POLR3B gene lead to 4H leukodystrophy from the study of brother and sister
Introduction: 4H leukodystrophy, one of POLR3-related leukodystrophy, is a rare hereditary brain white matter disease caused by the pathogenic biallelic variations in POLR3A, POLR3B, or POLR1C. Hypomyelination, hypodontia, and hypogonadotropic hypogonadism is mainly presented in patients with 4H leukodystrophy. Patient concerns: Here, we reported the brother and the sister with new compound heterozygous (c.1615G>T and c.165-167del) with various degrees of phenotypes including dysbasia, myopia, dental abnormal, and hypogonadotropic hypogonadism. Diagnosis: The brother and sister were diagnosed with 4H leukodystrophy. Interventions: Gonadotrophins treatment of the brother could significantly improve the development of secondary sexual characteristics and genitalia. Outcomes: This study showed that the same genotype of POLR3B may have variable clinical phenotypes in the brother and sister. Conclusion: The exploration of molecular functions and genetic counseling are crucial for further diagnosis and treatment of POLR3-related leukodystrophy.
- Open Access
- 16 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
CEP128 is involved in spermatogenesis in humans and mice
Centrosomal proteins are necessary components of the centrosome, a conserved eukaryotic organelle essential to the reproductive process. However, few centrosomal proteins have been genetically linked to fertility. Herein we identify a homozygous missense variant of CEP128 (c.665 G > A [p.R222Q]) in two infertile males. Remarkably, male homozygous knock-in mice harboring the orthologous CEP128R222Q variant show anomalies in sperm morphology, count, and motility. Moreover, Cep128 knock-out mice manifest male infertility associated with disrupted sperm quality. We observe defective sperm flagella in both homozygous Cep128 KO and KI mice; the cilia development in other organs is normal—suggesting that CEP128 variants predominantly affected the ciliogenesis in the testes. Mechanistically, CEP128 is involved in male reproduction via regulating the expression of genes and/or the phosphorylation of TGF-β/BMP-signalling members during spermatogenesis. Altogether, our findings unveil a crucial role for CEP128 in male fertility and provide important insights into the functions of centrosomal proteins in reproductive biology.
- 16 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Open AccessCEP128 is involved in spermatogenesis in humans and mice
Centrosomal proteins are necessary components of the centrosome, a conserved eukaryotic organelle essential to the reproductive process. However, few centrosomal proteins have been genetically linked to fertility. Herein we identify a homozygous missense variant of CEP128 (c.665 G > A [p.R222Q]) in two infertile males. Remarkably, male homozygous knock-in mice harboring the orthologous CEP128R222Q variant show anomalies in sperm morphology, count, and motility. Moreover, Cep128 knock-out mice manifest male infertility associated with disrupted sperm quality. We observe defective sperm flagella in both homozygous Cep128 KO and KI mice; the cilia development in other organs is normal—suggesting that CEP128 variants predominantly affected the ciliogenesis in the testes. Mechanistically, CEP128 is involved in male reproduction via regulating the expression of genes and/or the phosphorylation of TGF-β/BMP-signalling members during spermatogenesis. Altogether, our findings unveil a crucial role for CEP128 in male fertility and provide important insights into the functions of centrosomal proteins in reproductive biology.
- Open Access
Novel Mutations in X-Linked, USP26-Induced Asthenoteratozoospermia and Male Infertility
Male infertility is a multifactorial disease with a strong genetic background. Abnormal sperm morphologies have been found to be closely related to male infertility. Here, we conducted whole-exome sequencing in a cohort of 150 Han Chinese men with asthenoteratozoospermia. Two novel hemizygous mutations were identified in USP26, an X-linked gene preferentially expressed in the testis and encoding a deubiquitinating enzyme. These USP26 variants are extremely rare in human population genome databases and have been predicted to be deleterious by multiple bioinformatics tools. Hematoxylin-eosin staining and electron microscopy analyses of the spermatozoa from men harboring hemizygous USP26 variants showed a highly aberrant morphology and ultrastructure of the sperm heads and flagella. Real-time quantitative PCR and immunoblotting assays revealed obviously reduced levels of USP26 mRNA and protein in the spermatozoa from men harboring hemizygous deleterious variants of USP26. Furthermore, intracytoplasmic sperm injections performed on infertile men harboring hemizygous USP26 variants achieved satisfactory outcomes. Overall, our study demonstrates that USP26 is essential for normal sperm morphogenesis, and hemizygous USP26 mutations can induce X-linked asthenoteratozoospermia. These findings will provide effective guidance for the genetic and reproductive counseling of infertile men with asthenoteratozoospermia.
Open AccessNovel Mutations in X-Linked, USP26-Induced Asthenoteratozoospermia and Male Infertility
Male infertility is a multifactorial disease with a strong genetic background. Abnormal sperm morphologies have been found to be closely related to male infertility. Here, we conducted whole-exome sequencing in a cohort of 150 Han Chinese men with asthenoteratozoospermia. Two novel hemizygous mutations were identified in USP26, an X-linked gene preferentially expressed in the testis and encoding a deubiquitinating enzyme. These USP26 variants are extremely rare in human population genome databases and have been predicted to be deleterious by multiple bioinformatics tools. Hematoxylin-eosin staining and electron microscopy analyses of the spermatozoa from men harboring hemizygous USP26 variants showed a highly aberrant morphology and ultrastructure of the sperm heads and flagella. Real-time quantitative PCR and immunoblotting assays revealed obviously reduced levels of USP26 mRNA and protein in the spermatozoa from men harboring hemizygous deleterious variants of USP26. Furthermore, intracytoplasmic sperm injections performed on infertile men harboring hemizygous USP26 variants achieved satisfactory outcomes. Overall, our study demonstrates that USP26 is essential for normal sperm morphogenesis, and hemizygous USP26 mutations can induce X-linked asthenoteratozoospermia. These findings will provide effective guidance for the genetic and reproductive counseling of infertile men with asthenoteratozoospermia.
- Open Access
- 8 January 2021
- Published by Springer Nature in Tropical Plant Biology
- Vol. 14 (1) , 82-92
Comparative Transcriptome Analysis Reveals Putative Genes Responsible for High Theacrine Content in Kucha (Camellia kucha (Chang et Wang) Chang)
- 8 January 2021
- Published by Springer Nature in Tropical Plant Biology
- Vol. 14 (1) , 82-92
Open AccessComparative Transcriptome Analysis Reveals Putative Genes Responsible for High Theacrine Content in Kucha (Camellia kucha (Chang et Wang) Chang)